arginine has been researched along with Hematologic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Konopleva, M; Lorenzi, PL; Tabe, Y | 1 |
| Lai, CMB; Lee, AYY; Smith, T | 1 |
| Andrzejak, R; Antonowicz-Juchniewicz, J; Chachaj, A; Dzietczenia, J; Kuliczkowski, K; Mazur, G; Szuba, A; Wróbel, T | 1 |
1 review(s) available for arginine and Hematologic Neoplasms
| Article | Year |
|---|---|
Amino acid metabolism in hematologic malignancies and the era of targeted therapy.
Topics: Amino Acids; Animals; Antineoplastic Agents; Arginine; Asparagine; Cysteine; Glutamine; Hematologic Neoplasms; Humans; Metabolic Networks and Pathways; Molecular Targeted Therapy; Tumor Microenvironment | 2019 |
2 other study(ies) available for arginine and Hematologic Neoplasms
| Article | Year |
|---|---|
Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series.
Topics: Aged; Anticoagulants; Arginine; Canada; Female; Fondaparinux; Gastrointestinal Neoplasms; Hematologic Neoplasms; Hemorrhage; Heparin; Humans; Male; Patient Acuity; Pipecolic Acids; Platelet Count; Retrospective Studies; Risk Adjustment; Sulfonamides; Thrombocytopenia | 2021 |
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
Topics: Adult; Aged; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Risk Factors | 2008 |